Jonathan is an MIT TechReview Innovator Under 35 (Asia-Pacific), InDaily 40 under 40 Entrepreneur, holds a Ph.D in Particle Physics and a Ph.D in Nanotech/BioPhotonics, ex founder of Life Whisperer AI Enhanced Fertility (Global Winner One-to-Watch, acquired in 2024), and now CEO of Qubigen Intelligent Drug Design. Qubigen has commercialized a unique Federated AI approach to drug design, helping to crack the world's toughest diseases by fostering a collaborative federated data approach for new medicines that no single company could develop on their own.